Matti Kankainen

5.1k total citations
85 papers, 2.4k citations indexed

About

Matti Kankainen is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Matti Kankainen has authored 85 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 16 papers in Oncology and 15 papers in Immunology. Recurrent topics in Matti Kankainen's work include CAR-T cell therapy research (11 papers), Probiotics and Fermented Foods (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Matti Kankainen is often cited by papers focused on CAR-T cell therapy research (11 papers), Probiotics and Fermented Foods (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Matti Kankainen collaborates with scholars based in Finland, United States and Sweden. Matti Kankainen's co-authors include Liisa Holm, Soile Tynkkynen, Teija Ojala, Willem M. de Vos, Pekka Varmanen, Kirsi Savijoki, Kerttu Koskenniemi, Tuula A. Nyman, Nisse Kalkkinen and Johanna Koponen and has published in prestigious journals such as Nucleic Acids Research, Circulation and Nature Communications.

In The Last Decade

Matti Kankainen

80 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matti Kankainen Finland 28 1.4k 622 370 300 270 85 2.4k
Mohammad Hossein Modarressi Iran 36 2.3k 1.6× 279 0.4× 500 1.4× 435 1.4× 109 0.4× 202 3.7k
Hanwei Cao China 29 1.8k 1.2× 588 0.9× 320 0.9× 389 1.3× 253 0.9× 42 3.8k
Pieter Rottiers Belgium 25 1.4k 1.0× 513 0.8× 216 0.6× 663 2.2× 282 1.0× 46 3.0k
Pallavi Garg United States 28 664 0.5× 536 0.9× 272 0.7× 463 1.5× 162 0.6× 46 2.5k
Vibeke Barkholt Denmark 27 911 0.6× 444 0.7× 118 0.3× 134 0.4× 250 0.9× 54 2.3k
Pachiyappan Kamarajan United States 27 1.3k 0.9× 486 0.8× 269 0.7× 88 0.3× 141 0.5× 51 2.6k
Tadashi Yoshida Japan 30 902 0.6× 373 0.6× 433 1.2× 178 0.6× 275 1.0× 188 2.6k
Dale E. Shuster United States 27 661 0.5× 434 0.7× 847 2.3× 495 1.6× 276 1.0× 67 3.7k
Kunihiko Kobayashi Japan 31 710 0.5× 1.4k 2.3× 381 1.0× 158 0.5× 442 1.6× 117 3.4k
Ki‐Jong Rhee South Korea 28 2.3k 1.6× 408 0.7× 870 2.4× 467 1.6× 145 0.5× 109 4.2k

Countries citing papers authored by Matti Kankainen

Since Specialization
Citations

This map shows the geographic impact of Matti Kankainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Kankainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Kankainen more than expected).

Fields of papers citing papers by Matti Kankainen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Kankainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Kankainen. The network helps show where Matti Kankainen may publish in the future.

Co-authorship network of co-authors of Matti Kankainen

This figure shows the co-authorship network connecting the top 25 collaborators of Matti Kankainen. A scholar is included among the top collaborators of Matti Kankainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Kankainen. Matti Kankainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Myllymäki, Mikko, Timo Järvinen, Mikko Keränen, et al.. (2024). Somatic mutations associate with clonal expansion of CD8 + T cells. Science Advances. 10(23). eadj0787–eadj0787. 1 indexed citations
2.
Kankuri, Esko, Piet Finckenberg, J. Leinonen, et al.. (2023). Altered acylcarnitine metabolism and inflexible mitochondrial fuel utilization characterize the loss of neonatal myocardial regeneration capacity. Experimental & Molecular Medicine. 55(4). 806–817. 14 indexed citations
3.
Nieminen, Taina T., Mika Kontro, Matti Kankainen, et al.. (2023). Identification of DHX40 as a candidate susceptibility gene for colorectal and hematological neoplasia. Leukemia. 37(11). 2301–2305. 1 indexed citations
4.
Kettunen, K, et al.. (2022). A novel partial de novo duplication of JARID2 gene causing a neurodevelopmental phenotype. Molecular Genetics & Genomic Medicine. 10(11). e2037–e2037. 2 indexed citations
5.
Nuutila, Kristo, Shintaro Katayama, Anita Laitinen, et al.. (2022). ATMP-classified, scalable, autologous cell spray for the treatment of skin wounds and assessment of its effects on wound healing clinically and on a molecular level. Burns. 49(5). 1144–1156. 5 indexed citations
6.
Huuhtanen, Jani, Oscar Brück, Karita Peltonen, et al.. (2021). Single-Cell Characterization of the Immune and Leukemic Cells Following Anti-TIM3 and Hypomethylating Agent Combination Therapy in Patients with AML or MDS. Blood. 138(Supplement 1). 801–801. 1 indexed citations
7.
Kankainen, Matti, et al.. (2021). Comparison of Structural and Short Variants Detected by Linked-Read and Whole-Exome Sequencing in Multiple Myeloma. Cancers. 13(6). 1212–1212. 7 indexed citations
8.
Awad, Shady Adnan, Matti Kankainen, & Satu Mustjoki. (2021). Mutational landscape of chronic myeloid leukemia: more than a single oncogene leukemia. Leukemia & lymphoma. 62(9). 2064–2078. 20 indexed citations
9.
Awad, Shady Adnan, Matti Kankainen, Teija Ojala, et al.. (2020). Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia. Blood Advances. 4(3). 546–559. 38 indexed citations
10.
Ojala, Teija, Andrew Lindford, Kirsi Savijoki, et al.. (2020). Metatranscriptomic assessment of burn wound infection clearance. Clinical Microbiology and Infection. 27(1). 144–146. 7 indexed citations
11.
Woodcock, Dan J., Sinja Taavitsainen, Matti Kankainen, et al.. (2020). Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy. Nature Communications. 11(1). 5070–5070. 42 indexed citations
12.
Dufva, Olli, Pilvi Maliniemi, Aleksandr Ianevski, et al.. (2019). Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity. Blood. 135(9). 597–609. 157 indexed citations
13.
Laulajainen‐Hongisto, Anu, Jura Numminen, Livije Kalogjera, et al.. (2019). Hierarchical clustering in evaluating inflammatory upper airway phenotypes; increased symptoms in adults with allergic multimorbidity. Asian Pacific Journal of Allergy and Immunology. 38(4). 239–250. 4 indexed citations
14.
Awad, Shady Adnan, Matti Kankainen, Olli Dufva, et al.. (2018). RUNX1 Mutations Identify an Entity of Blast Phase Chronic Myeloid Leukemia (BP-CML) Patients with Distinct Phenotype, Transcriptional Profile and Drug Vulnerabilities. Blood. 132(Supplement 1). 4257–4257. 5 indexed citations
15.
Awad, Shady Adnan, Matti Kankainen, Samuli Eldfors, et al.. (2017). Identification of Progression-Associated Mutations in Chronic Myeloid Leukemia (CML) By Comparative Genomic Analysis. Blood. 130. 250–250. 1 indexed citations
16.
Andersson, Noora, Bhagwan Yadav, Anniina Färkkilä, et al.. (2017). Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells. Gynecologic Oncology. 144(3). 621–630. 27 indexed citations
17.
Ojala, Teija, Matti Kankainen, Joana Castro, et al.. (2014). Comparative genomics of Lactobacillus crispatus suggests novel mechanisms for the competitive exclusion of Gardnerella vaginalis. BMC Genomics. 15(1). 1070–1070. 97 indexed citations
18.
Miettinen, Minja, Taija E. Pietilä, Riina A. Kekkonen, et al.. (2012). Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages. Gut Microbes. 3(6). 510–522. 44 indexed citations
19.
Kankainen, Matti, Riina A. Kekkonen, Ken A. Lindstedt, et al.. (2011). Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cells. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 3 indexed citations
20.
Kankainen, Matti & Liisa Holm. (2005). POCO: discovery of regulatory patterns from promoters of oppositely expressed gene sets. Nucleic Acids Research. 33(Web Server). W427–W431. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Hossein Modarressi Breakdown of academic impact, for papers by Hanwei Cao Breakdown of academic impact, for papers by Pieter Rottiers Breakdown of academic impact, for papers by Pallavi Garg Breakdown of academic impact, for papers by Vibeke Barkholt Breakdown of academic impact, for papers by Pachiyappan Kamarajan Breakdown of academic impact, for papers by Tadashi Yoshida Breakdown of academic impact, for papers by Dale E. Shuster Breakdown of academic impact, for papers by Kunihiko Kobayashi Breakdown of academic impact, for papers by Ki‐Jong Rhee
Rankless by CCL
2026